1
|
Zhao Z, Zhang J. Non-homogenous hyperreflectivity in choriocapillaris layer on OCTA implies early treatment with anti-VEGF for central serous chorioretinopathy. Ophthalmic Res 2022; 65:506-515. [DOI: 10.1159/000524488] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2022] [Accepted: 03/15/2022] [Indexed: 11/19/2022]
Abstract
Introduction: Optical coherence tomography angiography (OCTA) facilitates the detection of the choroidal neovascularization (CNV). This study explored the role of non-homogenous hyperreflectivity implying putative CNV in choriocapillaris layer on OCTA in central serous chorioretinopathy (CSCR).
Methods: Thirteen eyes out of 12 patients with CSCR were examined with OCTA. The non-homogenous hyperreflectivity was compared with the histological morphology of experimental CNV. The effect of intravitreal anti-vascular endothelial growth factor (VEGF) was evaluated by analyzing the changes of central macular thickness (CMT) and the height of subretinal fluid (SRF).
Results: Comparison of the non-homogenous hyperreflectivity on OCTA with the established CNV in two animal models strongly indicated these signals are putative CNV. During following-up, these non-homogenous hyperreflectivity in CSCR developed into visible CNV on OCTA. Moreover, anti-VEGF treatment was effective to reduce both the SRF and CMT in CSCR with non-homogeneous hyperreflectivity or secondary CNV within 2 months.
Conclusion: This study suggested that the non-homogenous hyperreflectivity on OCTA could be served as a diagnostic biomarker for putative CNV in CSCR, implying early treatment with anti-VEGF.
Collapse
|